Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human natural killer cell development.

Aharon G Freud1, Michael A Caligiuri

  • 1Medical Scientist Program, The Ohio State University, Columbus, OH 43210, USA.

Immunological Reviews
|November 15, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First-in-human study of FLT3 CAR-T cell therapy for relapsed acute myeloid leukemia.

NPJ precision oncology·2026
Same author

CDK4/6 inhibition sensitizes breast cancer to NK cell therapy by inducing immune-interactive surface proteins.

bioRxiv : the preprint server for biology·2026
Same author

Epigenetic activation of EBV BGLF4 determines antiviral-based regimen response in EBV+CNS lymphoproliferative disease.

Blood neoplasia·2026
Same author

Inhibition of NFAT after human uterus transplant promotes loss of tissue-resident NK cells and attendant pregnancy complications.

Science translational medicine·2026
Same author

Gene Regulatory Programs of NK Cells Show That NCAM1 (CD56) and KIRs Are Controlled by Genetically Polymorphic Distal Regulatory Elements.

European journal of immunology·2026
Same author

Human type-1 innate lymphoid cells control leukemia stem cell differentiation and limit acute myeloid leukemia development.

Nature communications·2026

Human natural killer (NK) cell development is poorly understood. Recent findings suggest secondary lymphoid tissues, like lymph nodes and tonsils, are key sites for human NK cell development, challenging the traditional bone marrow focus.

Area of Science:

  • Immunology
  • Cell Biology
  • Developmental Biology

Background:

  • Human natural killer (NK) cell development is less understood than B- or T-cell development.
  • Animal models have provided insights into NK cell homeostasis and repertoire generation but lack mechanistic detail for human development.
  • In vivo cellular intermediates and microenvironments for human NK cell development remain elusive.

Purpose of the Study:

  • To review recent findings on human natural killer (NK) cell development.
  • To discuss the implications of new data in the context of established lymphocyte development principles.
  • To highlight the emerging role of secondary lymphoid tissues in human NK cell development.

Main Methods:

  • Review of recent experimental data and observations.

Related Experiment Videos

  • Comparative analysis of NK cell populations in blood, bone marrow, lymph nodes, and tonsils.
  • Integration of findings with existing knowledge of lymphocyte development.

    • Main Results:

    • Newly described stages of human NK cell development are enriched in lymph nodes and tonsils.
    • This enrichment suggests secondary lymphoid tissues are principal sites for human NK cell development.
    • Findings challenge the long-held view of bone marrow as the sole primary site.

    Conclusions:

    • Recent data indicate a significant role for secondary lymphoid tissues in human NK cell development.
    • This shifts the paradigm from bone marrow-centric development to a broader understanding involving lymphoid organs.
    • Further research is needed to elucidate the mechanistic details within these microenvironments.